Latest News

In late February 2026, Golar LNG Limited reported fourth-quarter 2025 revenue of US$132.81 million and net income of US$10.36 million, alongside full-year 2025 revenue of US$393.52 million and net income of US$65.68 million, declared a US$0.25 per share dividend payable in March 2026, and confirmed completion of a share buyback totaling 4,675,710 shares for US$117.32 million. Together, the stronger year-on-year financial results, cash return through dividends, and reduced share count from...

Paradox Interactive (OM:PDX) has just expanded two of its core franchises, releasing the Rise from Ruin Culture Pack and Scorpion Update for Age of Wonders 4 and detailing the upcoming Warships of the Pacific cosmetic pack for Hearts of Iron IV. See our latest analysis for Paradox Interactive. Despite the latest game content launches, Paradox Interactive’s recent share price momentum has been weak. The SEK122.4 level sits against a 90 day share price return of 23.55% and a 1 year total...

If you are wondering whether Affirm Holdings at around US$49.77 still offers value or if the big move is already behind it, this article is for you. The stock has had a mixed run recently, with a 4.1% gain over the last 7 days, a 12.7% decline over the past month, a 32.8% decline year to date, a 6.4% gain over the last year, and a very large 3-year return of about 4x. Recent headlines have continued to focus on Affirm's role in the buy now, pay later space, including coverage of its merchant...

Capgemini (ENXTPA:CAP) has agreed to acquire Piterion to expand its global Product Lifecycle Management and Manufacturing Operations Management capabilities. The deal is aimed at strengthening support for industrial clients across the full product lifecycle, from design to operations. This transaction adds to Capgemini’s end to end services, alongside its recent client work and AI focused collaborations. Capgemini, trading at around €105.35, has faced sustained share price pressure, with...

Clariant (SWX:CLN) is back in focus after its 2025 results showed sales of CHF 3,915 million, compared with CHF 4,152 million a year earlier, alongside a net loss instead of prior net income. See our latest analysis for Clariant. The latest CHF7.55 share price reflects mixed sentiment, with a 1 day share price return of 2.58% but a 1 year total shareholder return decline of 22.32% and a 5 year total shareholder return decline of 53.98%. This suggests that longer term momentum has been weak...

MasTec (MTZ) is back on investors’ radar after releasing fourth quarter and full year 2025 results, along with fresh 2026 guidance, combining strong reported growth with ongoing questions around margins and cash generation. See our latest analysis for MasTec. MasTec’s latest earnings and 2026 guidance have come alongside strong price momentum, with a 30 day share price return of 15.8% and a year to date gain of 31.8%. The 1 year total shareholder return of 162.2% and 3 year total shareholder...

If you are wondering whether F.N.B at around US$16.31 is offering fair value or a potential bargain, looking closely at how it is priced against its fundamentals can be a useful next step. The share price has had mixed recent returns, with a 7 day return of a 4.2% decline, a 30 day return of a 13.7% decline, a year to date return of a 5.1% decline, and a 1 year return of 28.5%, a 3 year return of 44.8% and a 5 year return of 49.0%. Recent coverage has focused on F.N.B as a regional bank...

Universal Display (OLED) just extended its long term OLED material supply and license agreements with LG Display, reaffirming a key commercial tie that supports demand for its UniversalPHOLED materials in a crowded OLED market. See our latest analysis for Universal Display. Despite renewing a core agreement with LG Display and recently highlighting progress in white PHOLED lighting, Universal Display’s share price has had a 1 month share price return decline of 20.2% and a 1 year total...

If you are wondering whether Moderna's current share price reflects its true worth, you are not alone. Many investors are asking the same question as the market reassesses the mRNA pioneer. The stock recently closed at US$54.98, with returns of 10.3% over 7 days, 34.1% over 30 days and 78.2% year to date, while the 1 year return is 62.9% and the 3 and 5 year returns are 63.7% and 64.8% declines respectively. Recent headlines have focused on Moderna's mRNA platform and its pipeline beyond...

Why Credicorp’s revised dividend policy matters now Credicorp (NYSE:BAP) has put dividends at the center of the conversation, formally updating its dividend policy and tying future payouts to a detailed set of financial, legal, and solvency conditions. The move comes alongside a series of past and upcoming board meetings focused on dividend distributions and transfers between retained earnings and reserves, which gives investors fresh information on how the company thinks about capital...

Immunome earnings and shelf registration set the stage Immunome (IMNM) has drawn fresh attention after reporting a full year 2025 net loss of US$212.39 million, which was narrower than the prior year, alongside a new shelf registration for up to roughly US$156 million in common stock. See our latest analysis for Immunome. Against this backdrop, Immunome’s share price has been choppy, with a 7.68% 90 day share price return and a 12.14% 30 day share price decline. Yet longer term momentum...

Why Constellium is on investors’ radar today Constellium (NYSE:CSTM) is drawing attention after a strong past 3 months, with the stock showing a 40.5% total return and a 115.3% total return over the past year. For investors tracking industrial materials, that recent performance is prompting a closer look at how Constellium’s $8,449.0 million in revenue and $273.0 million in net income line up with its current share price of $25.49. See our latest analysis for Constellium. At a share price of...

Natural Beauty Bio-Technology (SEHK:157) has posted its FY 2025 first half results with revenue of HK$264.5 million and basic EPS of HK$0.005459, setting a very different tone from the losses recorded through FY 2024. The company has seen revenue move from HK$156.7 million in 1H 2024 to HK$196.9 million in 2H 2024 and then to HK$264.5 million in 1H 2025, while EPS shifted from losses of HK$0.015211 and HK$0.036542 in the two halves of 2024 to a small profit in the latest period, supported by...

Voyager Technologies (VOYG) just closed FY 2025 with Q4 revenue of US$46.7 million and a basic EPS loss of US$0.52. Trailing 12 month revenue came in at US$166.4 million against a full year EPS loss of US$2.89 and revenue growth of 15.4% over the past year. The company has seen quarterly revenue range from US$34.5 million to US$46.7 million this year, with basic EPS losses stretching from US$0.28 to US$3.45 per quarter. Trailing 12 month net income excluding extra items was a loss of US$116.1...

O-I Glass (OI) recently flagged tougher than expected trading in early 2026, citing softer European demand, temporary supply chain costs from factory closures, and pricing pressure in wine, while still keeping its full year guidance intact. See our latest analysis for O-I Glass. Those softer early 2026 trading conditions and European headwinds help explain why the 30 day share price return sits at a 29.89% decline and the year to date share price return is down 23.09%. At the same time, the 1...

Why Biohaven is back on traders' screens Biohaven (BHVN) is back in focus after upbeat analyst commentary on its epilepsy drug opakalim, stronger sentiment following a peer’s Phase 3 epilepsy result, and a sector wide reaction to US regulatory leadership changes. See our latest analysis for Biohaven. Despite a positive 1 day share price return of 0.59% to US$10.27 after the recent analyst commentary and sector tailwinds, Biohaven’s 30 day share price return of 11.47% and 1 year total...

In recent days, Thales has launched SkyDefender, a multi-layer integrated air and missile defence system spanning land, sea and space, while also advancing secure connectivity through new quantum-safe 5G security capabilities and eSIM-based partnerships with Verifone and Brazilian payments provider Cielo. Together, these developments highlight how Thales is pairing defence systems, AI and cybersecurity with eSIM-driven payments connectivity to position itself as a core technology partner...

Impro Precision Industries (SEHK:1286) has reported FY 2025 first half revenue of HK$2,449.9 million and basic EPS of HK$0.18, with trailing twelve month revenue at HK$5.1 billion and EPS at HK$0.39 framing the latest numbers in a broader context. Over the last three reported half year periods, revenue has moved from HK$2,402.5 million in 1H 2024 to HK$2,284.3 million in 2H 2024 and then to HK$2,449.9 million in 1H 2025, while basic EPS has shifted from HK$0.16 to HK$0.18 over the same span,...

John Wiley & Sons (WLY) is back in focus after reporting fiscal third quarter earnings that returned the business to profitability, alongside steady revenue, expanding AI driven research offerings, and active share repurchases. See our latest analysis for John Wiley & Sons. The recent Q3 profit rebound and ongoing buybacks appear to have shifted sentiment, with a 25.21% 1 month share price return and a 24.10% year to date share price return, even though the 1 year total shareholder return is...

Chinese Estates Holdings (SEHK:127) has reported FY 2025 first half revenue of HK$42.7 million, with basic EPS at a loss of HK$0.215 per share as the group continues to work through a weak earnings patch. The company has seen revenue move from HK$183.9 million in the first half of 2024 to HK$41.8 million in the second half of 2024 and HK$42.7 million in the latest period. Basic EPS losses shifted from HK$0.221 to HK$0.884 and then HK$0.215, setting up an earnings season where investors may...

If you are wondering whether Universal Health Services is offering fair value at around US$186.53, you are not alone. This article focuses on what the numbers say about the stock today. The share price has pulled back recently, with an 8.9% decline over the last 7 days and a 14.7% decline over the last 30 days. However, the 1 year and 3 year returns of 8.5% and 62.2% respectively still stand out. Recent news around Universal Health Services has focused on the company as a key player in the...

A.P. Møller - Mærsk (CPSE:MAERSK B) has temporarily suspended several shipping services connecting the Middle East with Europe and Asia, after the closure of the Strait of Hormuz created fresh security and fuel distribution challenges. See our latest analysis for A.P. Møller - Mærsk. The latest news comes after a choppy period for the stock. The 1-day share price return shows a decline of 1.39% and the 7-day share price return shows a decline of 5.88%. This is set against a 30-day share price...

Kanamoto (TSE:9678) opened its Q1 2026 scorecard with revenue of ¥55.2 billion and basic EPS of ¥106.72, setting the tone for how the new fiscal year is starting to shape up. The company has seen quarterly revenue move from ¥52.6 billion and EPS of ¥73.74 in Q1 2025 to ¥55.2 billion and EPS of ¥106.72 in the latest quarter, with the trailing twelve month EPS at ¥328.86 on revenue of ¥214.8 billion. For investors, the mix of higher recent EPS prints and a steady revenue base highlights...

Edison International (NYSE:EIX) secured a dismissal of a shareholder lawsuit challenging its wildfire risk disclosures. The case focused on statements made before the January 2025 Los Angeles wildfires. The ruling removes a specific litigation claim tied to how the company communicated wildfire exposure to investors. Edison International, the parent of Southern California Edison, sits at the center of ongoing debates around utility wildfire exposure and risk management in California. The...